Tuesday, July 31, 2018

LuckChain (BASH) Reaches One Day Volume of $0.00

LuckChain (CURRENCY:BASH) traded flat against the US dollar during the twenty-four hour period ending at 11:00 AM Eastern on July 22nd. LuckChain has a total market capitalization of $2.95 million and $0.00 worth of LuckChain was traded on exchanges in the last day. In the last week, LuckChain has traded up 18.6% against the US dollar. One LuckChain coin can now be purchased for about $0.0041 or 0.00000061 BTC on exchanges including YoBit and C-CEX.

Here is how other cryptocurrencies have performed in the last day:

Get LuckChain alerts: TokenPay (TPAY) traded 0.8% higher against the dollar and now trades at $3.73 or 0.00049977 BTC. GoNetwork (GOT) traded up 4.2% against the dollar and now trades at $0.56 or 0.00007564 BTC. SaluS (SLS) traded 3.3% higher against the dollar and now trades at $25.93 or 0.00347473 BTC. Nectar (NEC) traded 3.2% lower against the dollar and now trades at $0.32 or 0.00004241 BTC. HempCoin (THC) traded 8.3% lower against the dollar and now trades at $0.0707 or 0.00000947 BTC. ECC (ECC) traded down 2.1% against the dollar and now trades at $0.0006 or 0.00000008 BTC. Linda (LINDA) traded 5.4% lower against the dollar and now trades at $0.0016 or 0.00000022 BTC. VeriCoin (VRC) traded 2.5% higher against the dollar and now trades at $0.32 or 0.00004265 BTC. ToaCoin (TOA) traded 5.6% higher against the dollar and now trades at $0.0031 or 0.00000042 BTC. Phantasma (SOUL) traded 6.4% higher against the dollar and now trades at $0.13 or 0.00001698 BTC.

LuckChain Coin Profile

LuckChain (CRYPTO:BASH) is a PoW/PoS coin that uses the Scrypt hashing algorithm. LuckChain’s total supply is 715,868,299 coins. LuckChain’s official Twitter account is @Luck_Chain. LuckChain’s official message board is bbs.luckchain.org. The official website for LuckChain is luckchain.org.

LuckChain Coin Trading

LuckChain can be traded on the following cryptocurrency exchanges: C-CEX and YoBit. It is usually not possible to purchase alternative cryptocurrencies such as LuckChain directly using U.S. dollars. Investors seeking to acquire LuckChain should first purchase Ethereum or Bitcoin using an exchange that deals in U.S. dollars such as GDAX, Changelly or Gemini. Investors can then use their newly-acquired Ethereum or Bitcoin to purchase LuckChain using one of the exchanges listed above.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “BASHUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Sunday, July 22, 2018

OncoSec Medical (ONCS) Receives Coverage Optimism Rating of 0.09

News articles about OncoSec Medical (NASDAQ:ONCS) have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. OncoSec Medical earned a news sentiment score of 0.09 on Accern’s scale. Accern also assigned media coverage about the biotechnology company an impact score of 43.2515581770241 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Here are some of the headlines that may have effected Accern Sentiment’s rankings:

Get OncoSec Medical alerts: OncoSec Medical (ONCS) Given Buy Rating at Dawson James (americanbankingnews.com) OncoSec Presents Update from Triple Negative Breast Cancer Program at 3rd Global Insight Conference on Breast Cancer (finance.yahoo.com) OncoSec appoints Sara M. Bonstein as CFO and COO (seekingalpha.com) Oncosec Medical (ONCS) Appoints Sara M. Bonstein as CFO and COO (streetinsider.com) OncoSec Appoints Sara M. Bonstein as Chief Financial Officer and Chief Operating Officer (finance.yahoo.com)

ONCS stock traded down $0.02 during trading on Thursday, reaching $1.28. The company’s stock had a trading volume of 367,800 shares, compared to its average volume of 916,959. OncoSec Medical has a 1 year low of $0.88 and a 1 year high of $2.95. The firm has a market capitalization of $68.05 million, a PE ratio of -1.21 and a beta of 2.98.

A number of equities research analysts have issued reports on the company. Dawson James reiterated a “buy” rating on shares of OncoSec Medical in a research note on Monday. HC Wainwright set a $4.00 price target on OncoSec Medical and gave the stock a “buy” rating in a research note on Tuesday. Maxim Group set a $5.00 price target on OncoSec Medical and gave the stock a “buy” rating in a research note on Tuesday, May 8th. Finally, ValuEngine upgraded OncoSec Medical from a “sell” rating to a “hold” rating in a research note on Wednesday, May 2nd. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $4.33.

In other news, CFO Richard B. Slansky sold 84,984 shares of the firm’s stock in a transaction dated Thursday, July 5th. The stock was sold at an average price of $1.39, for a total transaction of $118,127.76. Following the completion of the transaction, the chief financial officer now owns 255,000 shares in the company, valued at $354,450. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Avtar S. Dhillon sold 37,575 shares of the firm’s stock in a transaction dated Thursday, July 5th. The shares were sold at an average price of $1.39, for a total value of $52,229.25. Following the transaction, the director now owns 181,002 shares of the company’s stock, valued at approximately $251,592.78. The disclosure for this sale can be found here. Insiders sold a total of 300,106 shares of company stock valued at $419,658 in the last quarter. 5.50% of the stock is currently owned by company insiders.

OncoSec Medical Company Profile

OncoSec Medical Incorporated, a biotechnology company, engages in developing DNA-based intratumoral immunotherapies in the United States. The company's investigational technology, ImmunoPulseis designed to enhance the local delivery and uptake of DNA-based immune-targeting agents, such as plasmid encoded IL-12 (tavokinogene telseplasmid or tavo) for the treatment of cancer.

Featured Story: Are analyst ratings accurate?

Insider Buying and Selling by Quarter for OncoSec Medical (NASDAQ:ONCS)

Thursday, July 19, 2018

Top Energy Stocks To Watch For 2019

tags:HERO,TRIP,CPRX,

Whether it is on the demand side in China, India, South Korea, or on the production side, in Brazil, Russia and more, emerging markets exchange traded funds have some exposure to oil prices. While the MSCI Emerging Markets Index allocates just 7.29 percent of its weight to the energy sector, oil prices play a part in the benchmark's performance.

For example, the MSCI Emerging Markets Index allocates almost 45 percent of its combined weight to China and South Korea, both of which are net oil importers. The index devotes 10.59 percent of its geographic exposure to Brazil and Russia, which are major crude producers.

Some emerging markets ETFs, including the WisdomTree Emerging Markets High Dividend Fund (NYSE: DEM), are better-suited for taking advantage of rising oil prices.

What Happened

The $2.25-billion DEM tracks the yield-weighted WisdomTree Emerging Markets High Dividend Index.

“The WT EM High Dividend Index was launched in 2007 to track the performance of the highest dividend-paying companies in the region,” WisdomTree said in a recent note.

“The index weights companies that rank in the highest 30 percent by dividend yield using annual cash dividends paid. Since its inception more than 10 years ago, the WT EM High Dividend Index has outperformed its benchmark, the MSCI Emerging Markets Index, by 151 basis points annually — raising the question about whether an investor really needs an active manager to outperform in this 'inefficient' asset class.”

Top Energy Stocks To Watch For 2019: Hercules Offshore Inc.(HERO)

Advisors' Opinion:
  • [By Ethan Ryder]

    Hero (CURRENCY:HERO) traded 2.1% higher against the dollar during the 1-day period ending at 23:00 PM E.T. on June 26th. In the last week, Hero has traded 9.8% lower against the dollar. One Hero token can currently be bought for $0.0935 or 0.00001542 BTC on exchanges including HitBTC and Qryptos. Hero has a market capitalization of $0.00 and approximately $985.00 worth of Hero was traded on exchanges in the last day.

Top Energy Stocks To Watch For 2019: TripAdvisor, Inc.(TRIP)

Advisors' Opinion:
  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was TripAdvisor, Inc. (NASDAQ: TRIP) which traded down about 8% at $38.47. The stock��s 52-week range is $29.50 to $50.95. Volume was 3.3 million compared to the daily average volume of 2.8 million.

  • [By Stephan Byrd]

    Schwab Charles Investment Management Inc. raised its holdings in Tripadvisor Inc Common Stock (NASDAQ:TRIP) by 16.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 633,261 shares of the travel company’s stock after purchasing an additional 87,859 shares during the period. Schwab Charles Investment Management Inc. owned 0.46% of Tripadvisor Inc Common Stock worth $25,895,000 at the end of the most recent reporting period.

  • [By Demitrios Kalogeropoulos]

    TripAdvisor�(NASDAQ:TRIP) shares shot up 39% last month, compared to a 2% increase in the S&P 500, according to data provided by S&P Global Market Intelligence.

  • [By Lisa Levin]

     

    Companies Reporting After The Bell Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion. Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion. The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion. Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million. Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion. LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion. Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion. TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million. The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million. A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion. Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million. Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million. ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million. KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13
  • [By Lisa Levin] Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPA) shares jumped 31.6 percent to $12.18 following TripAdvisor Q1 earnings beat. ZAGG Inc (NASDAQ: ZAGG) rose 26.5 percent to $14.55 after the company posted better-than-expected Q1 earnings. OPKO Health, Inc. (NASDAQ: OPK) shares gained 25 percent to $4.0234 following Q1 beat. Axon Enterprise, Inc. (NASDAQ: AAXN) jumped 23.5 percent to $55.12 following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent. Penn Virginia Corporation (NASDAQ: PVAC) gained 23.3 percent to $59.00 after reporting Q1 results. TripAdvisor, Inc. (NASDAQ: TRIP) rose 22.5 percent to $47.51 after the company reported stronger-than-expected results for its first quarter on Tuesday. Sears Holdings Corporation (NASDAQ: SHLD) shares surged 21.7 percent to $3.36. Amazon.com's partnership with Sears started in 2017 with an agreement to sell Kenmore-branded appliances online. On Wednesday, the companies announced an extension of their relationship to now include tire delivery and installations. EP Energy Corporation (NYSE: EPE) jumped 21.3 percent to $2.68 following Q1 results. LendingClub Corporation (NYSE: LC) surged 20.4 percent to $3.395 following better-than-expected Q1 earnings. Superior Industries International, Inc. (NYSE: SUP) gained 19 percent to $15.82 after reporting Q1 results. Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares rose 18.5 percent to $8.13 following Q1 results. Twilio Inc. (NYSE: TWLO) rose 18.3 percent to $52.47 after the company posted strong quarterly results. Cerus Corporation (NASDAQ: CERS) shares jumped 18.3 percent to $6.47 following quarterly results. IEC Electronics Corp. (NYSE: IEC) shares climbed 17 percent to $4.68 after reporting better-than-expected quarterly earnings. New Relic, Inc. (NYSE: NEWR) rose 16.8 percent to $90.10 following Q4 results. Gulfport Energy Corporation (NASDAQ: GPOR)

Top Energy Stocks To Watch For 2019: Catalyst Pharmaceuticals, Inc.(CPRX)

Advisors' Opinion:
  • [By Lisa Levin] Gainers Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study. Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing. ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating. Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook. TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy. Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday. Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital. Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00. SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday. Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40. Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance. Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins. Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr
  • [By Lisa Levin] Gainers Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing. Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study. Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook. Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital. TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy. Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance. ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating. Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011. InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS. Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy.. SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday. Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Joseph Griffin]

    Shares of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) have received a consensus rating of “Buy” from the seven research firms that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $6.25.

Friday, July 13, 2018

Top 5 Financial Stocks To Watch Right Now

tags:PNBK,UVSP,CME,IYF,BRKL,

The Walt Disney Company (DIS ) just released its second quarter financial results, posting adjusted earnings of $1.84 per share and revenues of $14.55 billion.

Disney is currently a Zacks Rank #3 (Hold), which is subject to change based on today’s results. Shares of Disney are down 8% over the last year, but have popped 2.8% over the last four weeks. The company also saw its stock price sink 0.70% on Tuesday to hit $101.76 per share prior to the release of its quarterly earnings results.

Disney stock is currently up 0.60% to $102.40 per share in after-hours trading shortly after its earnings report was released.

DIS:

Beat earnings estimates. The company posted adjusted earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.68 per share.

Beat revenue estimates. The company saw revenue figures of $14.55 billion, topping our consensus estimate of $14.23 billion.

Disney saw its quarterly revenues pop roughly 9% from $13.34 billion in the year-ago period. Meanwhile, the media and entertainment giant’s adjusted EPS figure climbed roughly 23% from $1.50 per share.

Top 5 Financial Stocks To Watch Right Now: Patriot National Bancorp Inc.(PNBK)

Advisors' Opinion:
  • [By Shane Hupp]

    Patriot National Bancorp (NASDAQ: PNBK) and Community Bank, N.A. (NYSE:CBU) are both finance companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations and profitability.

Top 5 Financial Stocks To Watch Right Now: Univest Corporation of Pennsylvania(UVSP)

Advisors' Opinion:
  • [By Stephan Byrd]

    Univest Co. of Pennsylvania (NASDAQ:UVSP) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a report issued on Wednesday.

  • [By Ethan Ryder]

    The Manufacturers Life Insurance Company raised its position in shares of Univest Co. of Pennsylvania (NASDAQ:UVSP) by 65.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 353,718 shares of the financial services provider’s stock after buying an additional 139,590 shares during the period. The Manufacturers Life Insurance Company’s holdings in Univest Co. of Pennsylvania were worth $9,799,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Univest Co. of Pennsylvania (UVSP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Financial Stocks To Watch Right Now: CME Group Inc.(CME)

Advisors' Opinion:
  • [By Stephan Byrd]

    First American Trust FSB grew its stake in CME Group Inc (NASDAQ:CME) by 4.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,167 shares of the financial services provider’s stock after buying an additional 639 shares during the period. First American Trust FSB’s holdings in CME Group were worth $2,650,000 at the end of the most recent reporting period.

  • [By Money Morning Staff Reports]

    Bitcoin prices slumped under $6,000 per coin on a day when futures contracts expired at CME Group Inc. (NYSE: CME).

    But despite the recent downturn, many cryptocurrency bulls expect that institutional investors will pour into the market.

  • [By Ethan Ryder]

    CME Group (NASDAQ:CME) was downgraded by investment analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research report issued on Thursday.

Top 5 Financial Stocks To Watch Right Now: Ishares Trust Dj Us Financial (IYF)

Advisors' Opinion:
  • [By Todd Shriber, ETF Professor]

    The challenges facing EUFN may indicate the ETF will be challenged to deliver compelling risk-reward for investors. EUFN's three-year standard deviation is 18.23 percent, or more than 500 basis points above the same metric on the iShares U.S. Financials ETF (NYSE: IYF).

Top 5 Financial Stocks To Watch Right Now: Brookline Bancorp Inc.(BRKL)

Advisors' Opinion:
  • [By Joseph Griffin]

    These are some of the headlines that may have effected Accern Sentiment Analysis’s scoring:

    Get Brookline Bancorp alerts: Head to Head Analysis: Brookline Bancorp (BRKL) & Kearny Financial (KRNY) (americanbankingnews.com) Head-To-Head Contrast: Brookline Bancorp (BRKL) versus Northfield Bancorp (NFBK) (americanbankingnews.com) The Zacks Analyst Blog Highlights: Kforce, Burlington Stores, Brookline Bancorp, Federated National Holding and Salem Media Group (finance.yahoo.com) Brookline Bancorp (BRKL) vs. Charter Financial (CHFN) Critical Comparison (americanbankingnews.com)

    A number of equities research analysts have recently issued reports on the company. BidaskClub upgraded Brookline Bancorp from a “buy” rating to a “strong-buy” rating in a research note on Wednesday. ValuEngine upgraded Brookline Bancorp from a “hold” rating to a “buy” rating in a research note on Wednesday, May 23rd. Finally, Zacks Investment Research upgraded Brookline Bancorp from a “hold” rating to a “buy” rating and set a $19.00 price target on the stock in a research note on Wednesday, May 16th. Two analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $17.17.

  • [By Joseph Griffin]

    Brookline Bancorp (NASDAQ: BRKL) and People's United Financial (NASDAQ:PBCT) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends.

  • [By Stephan Byrd]

    Brookline Bancorp, Inc. (NASDAQ:BRKL) – Equities research analysts at Piper Jaffray upped their Q3 2018 EPS estimates for shares of Brookline Bancorp in a research report issued on Thursday, May 3rd. Piper Jaffray analyst M. Breese now anticipates that the bank will post earnings of $0.28 per share for the quarter, up from their prior estimate of $0.27. Piper Jaffray has a “Hold” rating and a $16.50 price objective on the stock. Piper Jaffray also issued estimates for Brookline Bancorp’s Q4 2018 earnings at $0.29 EPS, FY2018 earnings at $1.08 EPS, Q1 2019 earnings at $0.29 EPS, Q3 2019 earnings at $0.30 EPS and FY2019 earnings at $1.18 EPS.

Wednesday, July 11, 2018

Brokerages Anticipate SAP SE (SAP) Will Announce Quarterly Sales of $7.11 Billion

Analysts forecast that SAP SE (NYSE:SAP) will post sales of $7.11 billion for the current quarter, according to Zacks. Six analysts have made estimates for SAP’s earnings, with the highest sales estimate coming in at $7.23 billion and the lowest estimate coming in at $6.94 billion. SAP reported sales of $6.36 billion in the same quarter last year, which would suggest a positive year over year growth rate of 11.8%. The business is expected to announce its next quarterly earnings report before the market opens on Thursday, July 19th.

On average, analysts expect that SAP will report full-year sales of $29.20 billion for the current financial year, with estimates ranging from $28.49 billion to $29.74 billion. For the next financial year, analysts expect that the business will report sales of $31.52 billion per share, with estimates ranging from $30.58 billion to $32.74 billion. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that follow SAP.

Get SAP alerts:

SAP (NYSE:SAP) last announced its quarterly earnings results on Tuesday, April 24th. The software maker reported $0.82 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.57 by $0.25. The firm had revenue of $5.26 billion during the quarter, compared to the consensus estimate of $5.30 billion. SAP had a return on equity of 18.33% and a net margin of 18.00%. The firm’s quarterly revenue was down .5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.73 EPS.

Several analysts have recently weighed in on SAP shares. Barclays raised their target price on SAP from $132.00 to $134.00 and gave the company an “overweight” rating in a research note on Wednesday, April 25th. Zacks Investment Research upgraded SAP from a “sell” rating to a “hold” rating in a research note on Monday, April 9th. Royal Bank of Canada restated a “neutral” rating and set a target price on shares of SAP in a research note on Tuesday, April 24th. Jefferies Financial Group started coverage on SAP in a research note on Friday, June 1st. They set a “buy” rating and a $140.00 target price for the company. Finally, DZ Bank restated a “buy” rating on shares of SAP in a research note on Wednesday, June 27th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and eleven have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $113.30.

Hedge funds have recently modified their holdings of the company. Raymond James & Associates lifted its position in shares of SAP by 7.9% during the fourth quarter. Raymond James & Associates now owns 287,516 shares of the software maker’s stock worth $32,305,000 after purchasing an additional 20,957 shares during the last quarter. Northern Trust Corp lifted its position in shares of SAP by 6.2% during the first quarter. Northern Trust Corp now owns 1,564,517 shares of the software maker’s stock worth $164,525,000 after purchasing an additional 90,998 shares during the last quarter. Royal Bank of Canada lifted its position in shares of SAP by 13.3% during the first quarter. Royal Bank of Canada now owns 692,387 shares of the software maker’s stock worth $72,811,000 after purchasing an additional 81,282 shares during the last quarter. Bank of New York Mellon Corp lifted its position in shares of SAP by 0.7% during the fourth quarter. Bank of New York Mellon Corp now owns 277,368 shares of the software maker’s stock worth $31,164,000 after purchasing an additional 1,993 shares during the last quarter. Finally, Sustainable Growth Advisers LP lifted its position in shares of SAP by 6.0% during the first quarter. Sustainable Growth Advisers LP now owns 3,099,490 shares of the software maker’s stock worth $325,943,000 after purchasing an additional 176,456 shares during the last quarter. 10.78% of the stock is currently owned by institutional investors and hedge funds.

Shares of SAP opened at $119.20 on Friday, Marketbeat.com reports. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.32 and a quick ratio of 1.32. The stock has a market cap of $143.89 billion, a PE ratio of 27.83, a price-to-earnings-growth ratio of 3.54 and a beta of 1.15. SAP has a 1-year low of $99.20 and a 1-year high of $121.94.

SAP Company Profile

SAP SE operates as an enterprise application software, and analytics and business intelligence company worldwide. It offers SAP HANA, which enables businesses to process and analyze live data; SAP Data Hub, a solution that enables businesses to manage data from various sources; SAP Cloud Platform, which enables businesses to connect and integrate applications; SAP BW/4HANA, a data warehouse solution; SAP Leonardo, a system that enables customers to make business sense and opportunity of disruptive technologies; and SAP Analytics Cloud, which leverages the intersection of business intelligence, planning, and predictive analytics.

Get a free copy of the Zacks research report on SAP (SAP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Saturday, July 7, 2018

The 5 Best Restaurant Stocks of 2018 (So Far)

This year hasn't been great for the broader restaurant industry. Leading companies, including Starbucks�and McDonald's, have been struggling with negative customer traffic trends as more diners opt to stay closer to home, or to have their food delivered.

A few restaurant chains have managed to buck that downtrend, though, and their business success has contributed to market-beating stock-price gains for shareholders.

Below, we'll take a closer look at a few of these outperforming chains.

A couple eating breakfast out.

Image source: Getty Images.

Domino's Pizza: Up 48%

Investors had been worried that Domino's�(NYSE:DPZ) impressive growth streak was coming to an end, but the pizza chain put those fears to rest in its fiscal first-quarter earnings report. That announcement revealed that sales gains sped up to an 8% pace from 4% in the prior quarter thanks to market share gains in both the U.S. and international segments. Domino's franchised business model, meanwhile, continued to show off its strength as operating margin jumped to 38% of sales from 31%. The company is hoping to continue expanding sales at existing locations at a healthy clip, but its long-term growth plans�center on building out its store base to an even deeper penetration in the U.S. and in other countries around the world. ��

Fiesta Restaurant Group: Up 53%

Fiesta Restaurant Group�(NASDAQ:FRGI), home of the Pollo Tropical and Taco Cabana fast-casual chains, is back in Wall Street's good graces after a tough 2017 that was marked by falling sales at existing locations and an overall net loss. Its rebound plan, which includes cost cuts, menu improvements, and increased marketing investments, appears to be working. Sales returned to modest growth in the Pollo Tropical segment and are looking better at Taco Cabana. Those gains represent just the first small step in bringing the business back toward the nearly 10% operating margin shareholders saw in 2015, up from roughly 3% today.�

Chipotle Mexican Grill: Up 55%

Former highflier Chipotle�(NYSE:CMG) has had an impressive rally this year. Investors are happy to see both sales and profits headed in the right direction after a brutal multiyear stretch of declines that was brought on by food safety issues in 2015. In the fiscal first quarter, revenue rose 2.2% as higher menu prices offset slight traffic declines. Profit margin jumped to 20% of sales from 18% a year ago. Investors betting on the stock today have to hope that new CEO Brian Niccol can extend those modestly positive results through a risky turnaround plan that includes new menu items and a revamped loyalty program.

BJ's Restaurants: Up 69%

California-based brewhouse chain BJ's Restaurants�(NASDAQ:BJRI) has had a good year so far. Comparable-store sales rose 4.2% in the first quarter, and while most of those gains came from higher menu prices, the restaurant was also aided by modestly higher customer traffic. BJ's has seen many of its newest menu initiatives, including slow-roast prime rib, hit a chord with in-store diners even as its delivery sales spike. CEO Greg Trojan and his team are hoping to press both of those advantages over the coming quarters, but investors are even more optimistic about the company's balanced approach to store launches. It plans to open six restaurants this fiscal year, down from 10 in 2017, and surpass 200 locations across just over 26 U.S. states.

Noodles & Co.: Up 131%

It might seem odd that the industry's biggest winner so far this year isn't growing. In fact, Noodles & Co. (NASDAQ:NDLS) recently posted a quarterly net loss while revenue decreased 5%. But that result still shot past investors' expectations by showing surprising progress in the casual-dining chain's recovery efforts. Noodles & Co. has lots of work ahead of it before it can snap out of its four-year stretch of annual net losses. Yet, with shares having fallen by over 80% since 2013, even modestly good news proved to be enough to spark at least a short-term rally in the stock.

Picking favorites

The above list offers investment opportunities that include powerful, established franchises in addition to struggling rebound candidates. If you prefer the first category, you might want to take a closer look at industry leader Domino's. As for those riskier turnaround options, Chipotle offers an attractive mix of brand power and modest growth expectations that could lay the foundation for solid long-term returns from here.

Thursday, July 5, 2018

Redfin: Weak Home Sales Data A Major Threat

By now, most real estate market observers have noted that it's not a good time to be a realtor. Existing home sales have been on the wane for several consecutive months, driven by a confluence of factors. Tight supply is the main one: homeowners are choosing to hold onto their properties for longer, and new construction isn't enough to keep up with fresh demand from first-time homebuyers. At the same time, put off by rising home prices, people are renting their homes at higher rates than in previous years, with Pew Research noting last year that the share of households that was renting their homes is at a 50-year high. None of this is good news for realtors, who rely on robust home turnover and a deluge of sales to earn their living.

Of all the technology IPOs of last year, none is as dependent on the real estate market as Redfin (NASDAQ:RDFN), the tech-enabled real estate brokerage that makes the bulk of its revenues from realtor commissions. Later this month, we'll come upon the one-year anniversary of Redfin's IPO at $15 per share. Early investors have clearly done well, but as you can see from the chart below, most of the gains in the stock were already had at the beginning of its life as a public company. Over the past few months, Redfin has traded in a jagged pattern without a clear direction.

Chart RDFN data by YCharts

Though I previously noted that Redfin might be a buy under $20, at its current share price of ~$24, the stock is slated for a correction - especially with real estate fundamentals so weak. Redfin is incapable of escaping the gravity of the real estate industry, which is encountering its first major stumble since the financial crisis. Unlike last time, the problem is not the hangover effect from a glut of subprime demand - rather, it's limited supply, rising (not falling) prices that are keeping buyers at bay, and a new tax code under the Trump administration that is less favorable to homeowners than before.

To touch on the last point in more detail - as most investors know, the tax reform act increased the standard deduction to $12,000 for individuals, nearly twice what it was before. This means that for the owners or prospective owners of moderately priced homes, the interest tax deduction may no longer be advantageous relative to the standard deduction - eliminating one of the bedrock textbook reasons to buy a home in the United States. The mortgage interest deduction has long been considered a sacred cow of the U.S. tax code, and it has remained in there - but now, it will benefit fewer taxpayers to take advantage of it.

In addition to that, the Trump tax plan also capped state, local, and property tax deductions to just $10,000. For taxpayers in high-tax states like California and New York (we'll touch on the latter in further detail), this makes homeownership even less appealing, as many of them will already be using up the full deduction on state income taxes with nothing left over to deduct for property taxes. Adding insult to injury, the mortgage interest deduction has also been capped to just $750k, or $250k less than the prior cap of $1 million. Unfavorable tax shifts have already hurt the pace of home sales in New York; the same effect is likely to spread into other high-valued coastal markets in which Redfin draws the lion's share of its revenues.

Redfin is up against several structural challenges that may take years to overcome. The company's revenue growth began decelerating last quarter in Q1, and that isn't likely to change when it reports earnings early next month. In three out of three times that Redfin has reported earnings since going public last summer, the stock has fallen by 5% or more - even after beating Wall Street estimates as it did in Q4 and Q1.

In my view, it's not a good time to make a bullish bet on the company. The entire real estate industry is undergoing chills, and Redfin can't do much to deviate from that weakness.

NAR data shows third consecutive month of contraction

Numerous data points this year have pointed to a slowdown in the housing market, but perhaps none is important as the monthly data package released by the National Association of Realtors (NAR), often considered the authoritative voice on the real estate market.

The data released two weeks ago covered the month of May; later this month, NAR will release data for June. According to NAR, May was the third consecutive month of declines in existing home sales. Sales were down 3% y/y, continuing a trend of protracted weakness in the market since the beginning of the year (January saw the biggest drop, as shown in the monthly chart below):

Figure 1. NAR monthly home sales data

Source: National Association of Realtors

Some other interesting highlights from the NAR report: first-time homebuyers fell to 31% of all existing home sales, down from 33% in the year-ago period. This corroborates the notion that many younger millennials are choosing to rent for longer periods of time before buying their first homes, causing a further lull in the housing market.

NAR's chief economist noted the following in the report:

Incredibly low supply continues to be the primary impediment to more sales, but there��s no question the combination of higher prices and mortgage rates are pinching the budgets of prospective buyers, and ultimately keeping some from reaching the market.��

With prices up, mortgage rates up, and tax code changes all favoring rentals to home-buying, real estate sales (and thus, the lifeblood of realtors and real estate agencies like Redfin) are facing a major threat.

Manhattan

The nation's unofficial capital and most famous real estate market deserves a special mention. As reported by CNBC, a new report from Douglas Elliman proclaimed that Manhattan real estate has had its worst Q2 since the financial crisis.

The island of Manhattan, of course, has long had intricacies and market dynamics that distinguished it from the rest of American real estate. But the freeze in America's largest real estate market certainly puts a damper on forecasts for the rest of the country. According to the report, sales in Manhattan fell 17% y/y in the second quarter (compared to single-digit declines reported in the NAR data for the country as a whole), while the average sale price declined 5% y/y to $2.1 million.

As usual, a number of local factors are to blame, in addition to the countrywide headwinds from the tax code and rising interest rates. The major New York-specific issue is a flood of new supply, particularly in the high-end luxury condo segment, where there is now a 16-month supply inventory (most agree that 5-6 months of supply denotes a healthy supply-demand balance in the real estate sector).

One factor that is often overlooked, however, is a slowdown in foreign buying activity. The Elliman report claims that apartment sales to foreign buyers are down by 40% y/y. This could in part be attributed to the global rout in emerging market stocks, where China's indices have entered into a bear market after falling more than 20% from recent highs. Wealthy foreigners are suddenly feeling less flush and buying fewer trophy properties in leading U.S. cities.

Redfin doesn't break out its revenues by market. Even so, it's fairly easy to judge that Manhattan is one of the company's most important markets and a large source of its revenues. If weakness in Manhattan bleeds over into Redfin's other important expensive coastal markets like San Francisco, San Jose, and Seattle, the company could see its first y/y revenue decline. Redfin has been dropping its listing fee to 1% (versus the 3% industry standard) in many of these high-priced markets in an attempt to win market share, but even these fee reductions might not be enough to stimulate growth if the broader market continues to contract.

Key takeaways

For all the negative noise on the real estate market, Redfin shares haven't dropped nearly enough. It has somewhat been protected by its facade of being a "technology" company, but at the end of the day, Redfin can't escape the fact that real estate sales and agent commissions are down - which are the lifeblood of its business.

Second-quarter earnings are coming up in August, and earnings releases have historically been a hugely negative catalyst for the stock. With most data sources pointing to unusual weakness in the real estate market in Q2, it's almost inevitable that Redfin will also post a disappointing quarter. In my view, it's a good time to exit this trade and stay on the sidelines until the real estate market returns to healthy conditions.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Wednesday, July 4, 2018

Constellation Brands Explains Why Rising Costs Are Hurting Profits Today

Alcoholic-beverage giant Constellation Brands�(NYSE:STZ) posted first-quarter earnings results last week that delivered mostly positive news to shareholders. The owner of the popular Corona and Modelo beer franchises met management's overall forecasts and stayed on pace to reach its fiscal 2019 sales and earnings targets.

Yet there was a lot more to this report than those top- and bottom-line figures, since Constellation is engaged in several projects aimed at spurring faster long-term growth at the expense of short-term profits.

Executives updated investors on that trade-off in a conference call with Wall Street analysts. Below, I've picked out a few of the highlights from that presentation.

A beer and snacks on a coffee table.

Image source: Getty Images.

Adding to the portfolio

The successful launches of Corona Premier and Corona Familiar are the first two major Corona initiatives in more than 25 years. Premier has achieved record speed to shelf with [volumes] increasing each month since launch. Familiar has already achieved a healthy [market] share of the category in its regional expansion with [volumes] outpacing our expectations. -- CEO Rob Sands

Constellation's beer portfolio didn't miss a beat this quarter, with depletion, a metric measuring consumption,�rising 9%. The national rollout of two new Corona brands is off to a good start, executives said, and the company stole more market share during the Cinco de Mayo and Memorial Day holidays with strong demand for Corona, Modelo, and Pacifico beers.

About those rising costs

Beer operating margin decreased 230 basis points to 37.8%, as the benefit of favorable pricing was more than offset by marketing investments, higher [cost of goods sold], and unfavorable foreign currency.-- CFO David Klein

The profitability of the beer business took a rare step backward, with margins dropping from 40% of sales to 38% of sales. Pricing trends continued improving, but that benefit was overwhelmed by higher spending. Marketing costs leapt to 11% of sales from 10% a year ago as Constellation shelled out cash to support the Corona releases and aggressive advertising around the Modelo and Pacifico brands. Executives said strengthening the brand is key to protecting its positive sales momentum.

Making bold moves

We still have significant spending plan[s] for the balance of the year, as our full-year [capital expenditure] guidance of $1.15 billion to $1.25 billion remains unchanged.-- Klein

Constellation Brands booked another significant financial gain from its investment in Canopy Growth, the cannabis producer that's giving it early access to what could become a large global market for cannabis-infused drinks.

Two men holding bottled beers.

Image source: Getty Images.

But management's capital spending plans go much further: Constellation is expecting to invest almost $900 million in upgrading and expanding its Mexican beer brewery network this year while continuing to hunt for new beer, wine, and spirits brands to add to its premium-focused portfolio.

Looking ahead

While our first half financial results are being impacted by the investments behind the marketing, innovation, and growth initiatives I noted earlier, we're confident that we'll produce top tier financial performance.-- Klein

Considering that the company has been boosting earnings at a 20% clip for the past five years, it was jarring for some investors to see profits decline in the first quarter. Management expects cost to rise at an even faster pace in the second quarter, too, due mainly to the cadence of advertising spending and new-product releases.

However, Sands and his executive team believe that the second half of the fiscal year will bring more profitable growth such that they'll meet their initial goals of roughly 10% sales and profit gains for the beer business and 3% growth in wine and spirits. These figures should translate into a 10% earnings expansion that, while below the company's prior 20% pace, is still far higher than the rate industry peers are achieving right now.